MedPath

Zero Ischemia Laparoscopic Partial Nephrectomy

Phase 2
Withdrawn
Conditions
Small Renal Mass
Interventions
Procedure: Renal Artery Embolization
Procedure: Partial Nephrectomy (Surgical Resection)
Registration Number
NCT02634385
Lead Sponsor
St. Joseph's Healthcare Hamilton
Brief Summary

Laparoscopic partial nephrectomy (LPN) is often reserved for patients with a small peripheral tumour, in the hands of an experienced surgeon since it demands a high degree of endoscopic skill. Renal vessel clamp for vascular control is a required step during standard LPN. However, this creates a time limiting step for the surgeon and induces renal injury via warm ischemia and reperfusion injury. This novel approach can substantially reduce renal injury during LPN via superselective embolization of level II renal arteries pre-operatively. This technique facilitates the performance of a clamp-less, zero-ischemia LPN, significantly simplifying the procedure by remove time thresholds within which to perform tumor excision. The preliminary results are promising; however, there is a need for further corroboration of their results, in addition to a randomized controlled trial comparing this modified, zero ischemia technique with standard LPN.

Detailed Description

The potential utility of a zero ischemia, laparoscopic, partial nephrectomy portends significant implications for both the surgeon and patient. Firstly, the technical difficulty of a partial nephrectomy will be reduced to a more achievable level owing mainly to the removal of a time limit on surgical resection. With the blood flow halted to downstream tissue containing the renal neoplasm from preoperative embolization, resection can be made to the tumor without clamping of the main renal arteries. This minimizes the ischemic time to non-neoplastic renal tissue, allowing for a renal protective effect. Without the need for clamping, the overall surgical operative time is drastically reduced. With excision made at the ischemic tissue, intra-operative bleeding and ease can be achieved. More surgeons can ultimately attempt at LPN by removing the single most limiting surgical factor, warm ischemic time.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • T1a renal cell carcinomas diagnosed by ultrasonography (US), computed tomography (CT) or fine needle aspiration
  • tumor size <4cm in diameter
  • predominant exophytic growth
  • intraparenchymal depth no greater than 1.5cm, with a minimum distance of 5mm from the urinary collecting system
Exclusion Criteria
  • predominant endophytic nature (depth </= 1.5 cm)
  • nearness (<0.5cm) of the tumor to the urinary collecting system
  • multiple ipsilateral lesions
  • pregnancy
  • allergy to intravenous contrast dye
  • absolute contraindications to surgical intervention

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Small Renal MassPartial Nephrectomy (Surgical Resection)Patient's with a small renal mass will be undergoing embolization prior to laparoscopic partial nephrectomy.
Small Renal MassRenal Artery EmbolizationPatient's with a small renal mass will be undergoing embolization prior to laparoscopic partial nephrectomy.
Primary Outcome Measures
NameTimeMethod
Warm ischemia timeDuration of Surgical Procedure

From renal vessel clamping to unclamping during nephrectomy (only if clamping has occurred). Calculated in minutes.

Mean estimated blood loss (measured in ml)Duration of Surgical Procedure

From the start of procedure (Nephrectomy), until the end of the procedure.

Extirpative timeDuration of Surgical Procedure

From initial renal tissue breach until completion of bolster placement. Calculated in minutes.

Secondary Outcome Measures
NameTimeMethod
Blood transfusionsFrom date of pre-op up to 6 months post-op

Prior to Embolization procedure and pre and post-nephrectomy.

Conversion to other type of surgery (i.e. Radical Nephrectomy)Duration of Surgical Procedure

Minutes from the start of procedure (Nephrectomy).

Mean hospital stay2-10 Days

Date admitted for procedure until date of discharge. Measure in calendar days.

Overall survival ratesUp to 24 months post-operatively.

Follow-up will be monitored.

Pathological Results (% of negative margins and benign versus malignant tumours).7 to 14 days post nephrectomy.

Pathology results are usually not released until 7-14 days post nephrectomy.

Identification of other complications (i.e. readmission, arteriovenous malformations)Up to 24 months post-operatively.

Complications will be monitored after patient is discharged up until two years post-operatively.

Trial Locations

Locations (1)

St. Joseph's Healthcare Hamilton - McMaster Institute of Urology

🇨🇦

Hamilton, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath